Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001503666 | SCV001708522 | likely benign | Dyskeratosis congenita, autosomal recessive 5; Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 | 2021-11-24 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV001275093 | SCV002535287 | likely benign | Dyskeratosis congenita | 2022-01-09 | criteria provided, single submitter | curation | |
Ambry Genetics | RCV004659277 | SCV005161500 | likely benign | Inborn genetic diseases | 2024-05-23 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001275093 | SCV001459847 | uncertain significance | Dyskeratosis congenita | 2020-03-11 | no assertion criteria provided | clinical testing |